It combines the powerful appetite and insulin regulation of a GLP-1 agonist with growth hormone support for body composition optimization
Recent literature has associated the use of GLP-1 receptor agonists with an increased likelihood of developing diabetic lumbosacral radiculoplexus neuropathy (DLRPN) and common fibular neuropathy (CFN), with a recently published case-control study on this topic indicating a 51% and 30% increased risk, respectively [9]
Know when your dose increases and to what level
Age-related macular degeneration (AMD): pathogenesis and therapy
This oral growth hormone secretagogue delivers real results from lean muscle gains to faster recovery, deeper sleep, and improved skin, hair, and joint health
This helps reduce cravings, control hunger, and support a healthier lifestyle